			Home About us Contact

IgG Concentration (igg + concentration)

Distribution by Scientific Domains

Medical Sciences	69%
Life Sciences	30%

Kinds of IgG Concentration

serum igg concentration

Selected Abstracts

Serum IgG Concentrations after Intravenous Serum Transfusion in a Randomized Clinical Trial in Dairy Calves with Inadequate Transfer of Colostral Immunoglobulins

JOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 1 2010
M. Chigerwe
Background: Plasma transfusions have been used clinically in the management of neonates with failure of passive transfer. No studies have evaluated the effect of IV serum transfusions on serum IgG concentrations in dairy calves with inadequate transfer of passive immunity. Hypothesis: A commercially available serum product will increase serum immunoglobulin concentration in calves with inadequate transfer of colostral immunoglobulins. Animals: Thirty-two Jersey and Jersey-Holstein cross calves with inadequate colostral transfer of immunoglobulins (serum total protein <5.0 g/L). Methods: Thirty-two calves were randomly assigned to either control (n = 15) or treated (n = 17) groups. Treated calves received 0.5 L of a pooled serum product IV. Serum IgG concentrations before and after serum transfusion were determined by radial immunodiffusion. Results: Serum protein concentrations increased from time 0 to 72 hours in both control and transfused calves and the difference was significant between the control and treatment groups (P < .001). Mean pre- and posttreatment serum IgG concentrations in control and transfused calves did not differ significantly. Median serum IgG concentrations decreased from 0 to 72 hours by 70 mg/dL in control calves and increased over the same time interval in transfused calves by 210 mg/dL. The difference was significant between groups (P < .001). The percentage of calves that had failure of immunoglobulin transfer 72 hours after serum transfusion was 82.4%. Conclusions and Clinical Importance: Serum administration at the dosage reported did not provide adequate serum IgG concentrations in neonatal calves with inadequate transfer of colostral immunoglobulins. [source]

CE-based noncompetitive immunoassay for immunoglobulin G in bovine colostrum products

ELECTROPHORESIS, Issue 21 2007
Jin Zhao
Abstract A CE-based noncompetitive immunoassay for IgG in bovine colostrum products was established. FITC-labeled protein G (FITC-PrG) was tagged through noncovalent bindings to the Fc region of the mouse monoclonal antibovine IgG (Ab). The FITC-PrG, Ab, and IgG formed a sandwiched immunocomplex FITC-PrG-Ab-IgG under optimal incubation conditions. The immunocomplex was separated and analyzed by CZE with LIF detection in less than 2,min in an uncoated fused-silica capillary. Addition of PEG 20,000 (PEG 20M) in the running buffer significantly suppressed analyte adsorption and thus improved the reproducibility and the resolution. The precision of the method was 5.1% (n,=,7). A linear relationship was established for the IgG concentration in the range of 1,5,mg/L with a linear correlation coefficient (r,=,0.9917). The LOD was 0.1,mg/L (S/N,=,3). The method was successfully applied for the determination of IgG in bovine colostrum products and satisfactory results were achieved. [source]

Untersuchungen zur prophylaktischen Wirkung der Verfütterung eines Probiotikums und von erregerspezifischen Kolostrum- und Dotterantikörpern bei neugeborenen Kälbern

JOURNAL OF ANIMAL PHYSIOLOGY AND NUTRITION, Issue 3-4 2000
M. H. Von Erhard
Studies on the prophylactic effect of feeding probiotics, pathogen-specific colostrum antibodies or egg yolk antibodies in newborn calves The prophylactic efficacy of feeding probiotics, specific egg yolk antibodies and specific colostrum antibodies on neonatal diarrhoea was investigated in a field trial with calves, grouped (n = 39/40 per group) according to the following treatments: Group I: feeding no additive; Group II: feeding probiotics (5 g powder/day with Bacillus cereus var. toyoi); Group III: feeding egg powder (10 g/day with specific egg yolk antibodies against rotavirus, coronavirus and Escherichia coli F5); Group IV: feeding colostrum antibodies (10 ml/day containing 1 g bovine immunoglobulins with specific antibodies against rotavirus, coronavirus and E. coli antigens); Group V: feeding egg powder together with probiotics (according to group II and III). The additives were given twice daily with the meal from day 2 to day 14 post-natum. The presence of infectious agents was proved in fecal samples of all calves. Intestinal infections with rotavirus (30.8% of the calves) predominated compared to those with coronavirus (7.1%), E. coli F5 (1.5%) and cryptosporidia (24.2%). In contrast to earlier studies, the manifestation of diarrhoea did not differ significantly between the five groups. Only the growth rate of the calves between day 2 and day 14 of life as a measure of their welfare showed treatmentFspecific differences. The control group (I) showed the lowest body weight gain of about 5.8 kg (SD 5.0), whereas in the treated groups it averaged 6.3 kg (SD 4.1, p = 0,60; group II), 6.8 kg (SD 4.3, p = 0.36; group III), 6.9 kg (SD 4.7, p = 0.61; group IV) and 7.7 kg (SD 4.9, p = 0.08; group V). Considering only the rotavirus-positive calves the body weight gain of the control group (I) was 3.5 kg (SD 4.8) and of the treated groups was 3.8 kg (SD 3.3, p = 0.65; II), 5.0 kg (SD 3.5, p = 0.54; III), 6.6 kg (SD 4.5, p = 0.05; IV) and 6.1 kg (SD 5.0, p = 0.13; V). Obviously, the feeding of antibodies from colostrum or from egg powder does increase the mean body weight gain. The feeding of probiotics alone has nearly no effect. However, in the combination with specific egg antibodies probiotics seem to have a synergistic effect. In serum from the 198 newborn calves the IgG concentration averaged 4.9 mg/ml serum (SD 3.3). From 93 dams of these calves a sample of the first colostrum could be obtained showing a mean IgG concentration of 22.0 mg/ml (SD 11.0). IgG levels in the colostrum and in the serum have been positively correlated (r = 0.37, p < 0.05). Calves with a high intensity of diarrhoea had a significantly (p = 0.01) lower mean IgG serum level (3.7 mg/ml; n = 36; SD 2.5) than calves without diarrhoea (5.6 mg/ml; n = 75; SD 4.0). In Rahmen eines Feldversuches wurde die prophylaktische Wirksamkeit verschiedener Futteradditiva (Probiotikum, spezifische Dotterantikörper, spezifische Kolostrumantikörper) bei der neonatalen Kälberdiarrhoe untersucht. Dazu wurden die Kälber entsprechend der Behandlung in folgende fünf Gruppen (je n = 39/40) eingeteilt: I: Keine Futterzusatzstoffe, II: Verfütterung eines Probiotikums (5 g Pulver/Tag mit Bacillus cereus var. toyoi), III: Verfütterung von Eipulver (10 g/Tag mit spezifischen Dotterantikörpern gegen Rotaviren, Coronaviren und E. coli F5), IV: Verfütterung von Kolostrumantikörpern (10 ml/Tag mit 1 g bovinen Immunglobulin mit spezifischen Antikörpern gegen Rotaviren, Coronaviren und Escherichia coli Antigene), V: Verfütterung von Eipulver zusammen mit einem Probiotikum (analog den Gruppen II und III). Die Prophylaktika wurden zwei Mal täglich vom 2. bis zum 14. Lebenstag mit der Tränke verabreicht. Bei allen Kälbern wurde ein Erregernachweis im Kot geführt. Rotaviren (30,8%) konnten im Vergleich zu Coronaviren (7,1%), E. coli F5 (1,5%) und Kryptosporidien (24,2%) häufiger nachgewiesen werden. Im Gegensatz zu früheren Studien konnten hinsichtlich des Durchfallgeschehens keine signifikanten Unterschiede zwischen den Gruppen festgestellt werden. Nur die Körperge wichtszunahme der Kälber zwischen 2. und 14. Lebenstag zeigte behandlungsspezifische Unterschiede. Die Kontrollgruppe (I) verbuchte mit 5,8 kg (SD 5,0) die niedrigste Körpergewichtszunahme. Verglichen damit lag die Zunahme der behandelten Gruppen bei 6,3 (SD 4,1; p = 0,60; Gruppe II), 6,8 kg (SD 4,3; p = 0,36; Gruppe III), 6,9 kg (SD 4,7, p = 0,61; Gruppe IV) und bei 7,7 kg (SD 4,9, p = 0,08; Gruppe V). Bei Rotavirus-positiven Kälbern war eine Körpergewichtszunahme von 3,5 kg (SD 4,8; Kontrollgruppe), 3,8 kg (SD 3,3, p = 0,65; Gruppe II), 5,0 kg (SD 3,5, p = 0,54; Gruppe III), 6,6 kg (SD 4,5, p = 0,05; Gruppe IV) und von 6,1 kg (SD 5.0, p = 0,13; Gruppe V) zu verzeichnen. Offensichtlich verhindert die prophylaktische Verfütterung von Kolostrum- oder Dotterantikörpern eine infektionsbedingte Verminderung der Körpergewichtszunahme. Die Applikation des Probiotikums alleine zeigte keinen vergleichbaren Effekt. Allerdings ist eine synergistische Wirkung in Kombination mit Antikörpern nicht auszuschließen. In den Seren der 198 neugeborenen Kälber wurde eine mittlere Immunglobulin G (IgG)-Konzentration von 4,9 mg/ml (SD 3,3) gemessen. Von 93 Muttertieren dieser Kälber konnte das Erstgemelk genommen werden, das eine mittlere IgG-Konzentration von 22,0 mg/ml (SD 11,0) aufwies. Die IgG-Gehalte in den Kolostrumproben und den Kälberseren zeigten eine Korrelation von r = 0,37 (p < 0,05). Kälber mit hochgradigem Durchfall hatten mit 3,7 mg/ml Serum (n = 36, SD 2,5) einen signifikant niedrigeren mittleren IgG-Wert als Kälber ohne Durchfall (5,6 mg/ml, n = 75, SD 4,0). [source]

Serum Immunoglobulin G Concentrations in Calves Fed Fresh Colostrum or a Colostrum Supplement

JOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 2 2002
Nicole M. Holloway
This study compared serum immunoglobulin G (IgG) concentrations in calves fed colostrum with those of calves fed a colostrum supplement containing spray-dried serum. Twenty-four Holstein calves were randomly assigned to 1 of 2 treatment groups (fresh colostrum or colostrum supplement). Each calf was fed 4 L of colostrum (n1= 12) or 4 L of colostrum supplement (n2= 12) via oroesophageal intubation at 3 hours of age. The concentration of the colostrum supplement fed to calves was twice the manufacturer's recommendation. The median and range values for colostral IgG concentration were 6,430 mg/dL and 1,400-17,000 mg/ dL, respectively. Median serum IgG concentrations at 2 days of age differed significantly (P= .001) between calves receiving fresh colostrum (3,350 mg/dL) and the colostrum supplement (643 mg/dL). Eight percent of calves force fed colostrum had serum IgG concentrations <1,000 mg/dL, whereas 75% of calves force-fed supplement had IgG concentrations below this threshold. The calculated population relative risks for mortality associated with passive transfer for calves force-fed colostrum and calves force-fed colostrum supplement were 1.09 and 1.90, respectively. Force-fed fresh colostrum is superior to the colostrum supplement studied, but the colostrum supplement has similar efficacy to routine colostrum administration practices. [source]

B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient

PEDIATRIC TRANSPLANTATION, Issue 1 2001
R. Ganschow
Abstract: The use of mycophenolate mofetil (MMF) in combination with cyclosporin A (CsA) and steroids is well established after kidney transplantation (Tx) in children. A 9-yr-old girl with primary hyperoxaluria type 1 and systemic oxalosis underwent a combined kidney and liver Tx at our institution. The post-operative immunosuppression consisted of CsA, prednisolone, and MMF. Four weeks post-transplant the girl suffered from a severe urinary tract infection caused by Pseudomonas aeruginosa, when the serum immunoglobulin G (IgG) concentration was found to be critically low (< 1.53 g/L). Additionally, there was an isolated B-cell depletion (240/µL) at that time. In the following course, the B-cell count was significantly diminished until the MMF was stopped 13 weeks post-transplant. As a result of the very low serum IgG concentration, intravenous immunoglobulin (IVIG) substitution was necessary. There was no significant loss of immunoglobulins in the ascites and urine and no other medication with possible side-effects on B cells was given. We suggest that MMF can lead to suppressed IgG production by B cells and can cause a defective differentiation into mature B cells. In vitro studies demonstrated these effects of MMF on B cells, but no in vivo cases of this phenomenon have been reported. B-cell counts and serum IgG concentrations returned to normal values after discontinuing the MMF. As we can assume that the observed B-cell dysfunction and depletion were MMF related, we suggest that serum IgG concentrations should be monitored when MMF is used after solid-organ Tx. [source]

Clinical impact of altered immunoglobulin levels in Henoch,Schönlein purpura

PEDIATRICS INTERNATIONAL, Issue 3 2009
Andrew Fretzayas
Abstract Background:, The aim of the present study was the identification of immunological features, present at the time of diagnosis, that would predict the severity of Henoch,Schönlein purpura and its outcome. Methods:, A cohort study was carried out in a tertiary pediatric hospital of 69 children with Henoch,Schönlein purpura, in whom serum complement components C3, C4 and IgA, IgM, IgG were repeatedly determined. Results:, During the acute phase of the disease in 54/69 patients (78.3%) immunological imbalances were observed. In 24/54 cases (44.4%) certain complications involving the kidneys and the gastrointestinal tract were noted as opposed to in 3/15 children (20%) without immunologic abnormalities. In 50/69 children (72.5%), elevated serum IgA was detected and 16 of them (32%) developed renal involvement while only 1/19 children (5.3%) with normal IgA concentration had renal involvement. Considering separately the group of 9/69 children (13%) with increased IgM and those with normal IgM levels (53/69; 76.8%), irrespective of IgA and IgG concentration, we found a comparable percentage of children who had both renal and intestinal involvement without, however, developing severe complications, which were exclusively seen in patients with increased IgA (5/7 children) and reduced IgM levels. Serum C3 fraction was elevated in 26 children (37.7%) and in 73% of cases it was associated with increased serum IgA values. Conclusion:, Renal involvement was seen in 32% of children with increased IgA values. Most importantly, elevated IgA concentration along with reduced IgM levels was associated with higher prevalence of severe complications. [source]

A cell preparation of Enterococcus faecalis strain EC-12 stimulates the luminal immunoglobulin A secretion in juvenile calves

ANIMAL SCIENCE JOURNAL, Issue 2 2009
Takeshi TSURUTA
ABSTRACT The immune system in juvenile calves is immature, so calves are susceptible to several diarrheal and respiratory diseases. Oral administration of lactic acid bacteria (LAB) is known to improve the growth performance and prevent diarrheal and respiratory diseases by stimulating the immune system in juvenile calves. Most of the immunostimulation by LAB is achieved by their cell wall components, and therefore we evaluated the immunostimulation of the cell preparation of Enterococcus faecalis strain EC-12 (EC-12) in juvenile calves in a clinical field. Twenty-nine 1-week old calves were used. Fourteen calves were administered 0.2% (w/w) of an EC-12 preparation that supplemented a milk replacer, and other calves were not supplemented. Feces and serum was collected at day 0, 7 and 49 after the administration to measure the IgA and IgG concentration. The fecal IgA concentration was increased by EC-12 administration at day 49, and the serum IgA concentration was also increased at day 7. These results suggested that oral administration of EC-12 in juvenile calves might have an immunostimulatory effect and provide earlier recovery of IgA levels in mucosal immunity. [source]

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease

ARTHRITIS & RHEUMATISM, Issue 6 2010
Arezou Khosroshahi
Objective Patients with IgG4-related systemic disease (IgG4-RSD) frequently show an incomplete response to treatment with glucocorticoids and traditional disease-modifying antirheumatic drugs (DMARDs). B lymphocyte depletion is a therapeutic strategy known to be effective for pemphigus vulgaris, an autoimmune condition mediated by IgG4 autoantibodies. This study was performed to assess the clinical and serologic responses to B lymphocyte depletion therapy with rituximab in patients with IgG4-RSD. Methods Four patients with IgG4-RSD were treated with 2 intravenous doses (1 gram each) of rituximab. Clinical improvement was assessed by monitoring the tapering/discontinuation of prednisone and DMARDs, and by measuring the serum concentrations of B lymphocytes, immunoglobulins, and IgG subclasses before and after therapy. Results Clinical features of IgG4-RSD in these 4 patients included autoimmune pancreatitis, sclerosing cholangitis, lymphoplasmacytic aortitis, salivary gland involvement, orbital pseudotumor, and lacrimal gland enlargement. The 3 patients with elevated serum IgG and IgG4 levels at baseline had a mean IgG concentration of 2,003 mg/dl (normal range 600,1,500 mg/dl) and a mean IgG4 concentration of 2,160 mg/dl (normal range 8,140 mg/dl). Among these patients, the serum IgG4 concentrations declined by a mean of 65% within 2 months of rituximab administration. All 4 patients demonstrated striking clinical improvement within 1 month of the initiation of rituximab therapy, and tapering or discontinuation of their treatment with prednisone and DMARDs was achieved in all 4 patients. A decrease in IgG concentration was observed for the IgG4 subclass only. Conclusion Treatment with rituximab led to prompt clinical and serologic improvement in these patients with refractory IgG4-RSD, and is a viable treatment option for this condition. The decline in serum IgG4 concentrations was substantially steeper than that of the autoantibody concentrations in immune-mediated conditions in which rituximab is effective, such as in rheumatoid arthritis. In addition, the reduction in IgG-subclass levels appeared to be specific for IgG4. The swift improvement of IgG4-RSD suggests that rituximab achieves its effects in IgG4-RSD by depleting the pool of B lymphocytes that replenish short-lived IgG4-secreting plasma cells. [source]

Effect of antibody solution conditions on filter performance for virus removal filter PlanovaÔ 20N

BIOTECHNOLOGY PROGRESS, Issue 4 2010
Tomoko Hongo-Hirasaki
Abstract We investigated the effect of antibody solution conditions (ionic strength, pH, IgG concentration, buffer composition, and aggregate level (dimer content)) on filter performance for a virus removal filtration process using the PlanovaÔ 20N, a virus removal filter. Ionic strength and pH affected the filter flux. A consistent high flux was maintained at an ionic strength greater than 10 mM and at pH 4,8 under a typical buffer composition (sodium chloride, citrate, acetate, and phosphate). Optimum IgG concentration was 10,20 mg/mL allowing for high throughput (kg/m2 of IgG). Dimer content negligibly affected the flux level. Under high throughput conditions, virus spiking did not affect flux whereas a parvovirus logarithmic reduction value greater than 5 was maintained. From the results of zeta potential analyses for IgG and the membrane, we considered that electrostatic interactions between antibodies and the membrane affect filter performance (flux level and throughput). These results indicate that the PlanovaÔ 20N filter is applicable for a wide range of solution conditions typically used in antibody processing. © 2010 American Institute of Chemical Engineers Biotechnol. Prog., 2010 [source]

Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromes

EUROPEAN JOURNAL OF NEUROLOGY, Issue 6 2007
O. Stich
Using isoelectric focusing and affinity blotting employing paraneoplastic recombinant antigens, we investigated cerebrospinal fluid (CSF) and sera from three patients with positive anti-CV2/CRMP5- and one patient with positive anti-amphiphysin serology. CSF and sera were previously adjusted to total IgG concentrations of 20 mg/l. All patients suffered from paraneoplastic neurological syndromes (PNS) with predominant involvement of the central nervous system (CNS). Using affinity blot preloaded with paraneoplastic antigen, we detected in three of four patients more or stronger specific oligoclonal bands (OCB) in the CSF than in the corresponding serum, providing qualitative evidence of antigen specific intrathecal antibody synthesis. These results are in line with previous studies demonstrating specific OCB predominantly in CSF from patients with anti-Hu-, anti-Yo- and anti-Ri-associated PNS, supporting the hypothesis of autoimmunity in the pathogenesis of PNS. One patient harboured extensive anti-amphiphysin specific OCB, although OCB of total IgG could not be detected, indicating a higher sensitivity for detection of intrathecal antibody synthesis of the affinity blot preloaded with the paraneoplastic antigen, compared with investigation of total IgG OCB. These results could have implications concerning pathophysiological autoimmune aspects in other inflammatory diseases of CNS associated with total IgG OCB, provided that the target antigen is known. [source]

Mucosal Production of Antigastric Autoantibodies in Helicobacter pylori Gastritis

HELICOBACTER, Issue 3 2000
Gerhard Faller
Background. Apart form bacterial virulence factors of Helicobacter pylori, certain host factors influence the pathogenesis of H. pylori gastritis. In particular, antigastric autoantibodies that are detectable in the sera of a substantial proportion of H. pylori were shown to correlate with the development of gastric atrophy. The aim of this study was to analyze the possible antigastric autoimmune response in H. pylori gastritis at the site where the action is, i.e., in the gastric mucosa. Material and Methods. Gastric biopsy specimens from antrum and corpus mucosa of 24 H. pylori,infected and of 33 noninfected patients were cultured for 3 days, and tissue culture supernatants were analyzed for the amount of locally produced IgA and IgG. Antigastric autoantibodies were screened in the sera and in the supernatants by means of immunohistochemistry. Results. The infected patients had significantly higher concentrations of locally produced IgA, whereas the IgG concentrations were virtually the same in infected and noninfected patients. IgG or IgA antigastric autoantibodies, or both, were detectable only in the sera (38%) and supernatants (17%) of infected patients. Interestingly, the patient with the strongest local autoimmune response showed body-predominant H. pylori gastritis, with destruction of gastric glands and atrophy of the body mucosa. Conclusions. These results demonstrate that antigastric autoimmune reactions are detectable at the site of the disease and might be relevant for the pathogenesis of gastric mucosa atrophy in H. pylori gastritis. [source]

Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response

JOURNAL OF MEDICAL VIROLOGY, Issue 1 2008
R. Bendall
Abstract Sequential sera were collected from 18 acute cases of UK-acquired hepatitis E. The virus strains in all cases were of genotype 3. The IgM and IgG response to acute infection were documented over time using EIA kits based on a peptide antigen, pE2, which is derived from a genotype 1 strain of hepatitis E virus (HEV). Ninety-five percentage of acute sera were IgM positive; after 6 months or more only 12% remained positive. The kit was adapted to quantify the IgG response (in WHO U/ml) and to determine antibody avidity. Following acute infection, anti-HEV IgG concentrations rose between 6.9- and 90-fold. IgG avidity was low (<25%) in most acute sera. After 6 months IgG avidity was greater than 50% in all cases. One patient with a poor IgM response and high avidity antibody in acute sera may have had a second HEV infection. Taken together, these results confirm that the pE2-based EIA kits are suitable for diagnosing acute HEV genotype 3 infection. With simple modifications the IgG kit can measure anti-HEV concentration and avidity, which can be used to confirm acute infection. J. Med. Virol. 80:95,101, 2008. © 2007 Wiley-Liss, Inc. [source]

Serum IgG Concentrations after Intravenous Serum Transfusion in a Randomized Clinical Trial in Dairy Calves with Inadequate Transfer of Colostral Immunoglobulins

Serum IgM Concentrations in Normal, Fit Horses and Horses with Lymphoma or Other Medical Conditions

JOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 3 2003
G.A. Perkins
The purposes of this study were to (1) prospectively establish serum IgM and IgG concentrations in normal, fit, adult horses over time and (2) determine the accuracy of serum IgM concentrations for diagnosing lymphoma. Serial IgM and IgG concentrations were measured with a radial immunodiffusion assay in 25 regularly exercised horses at 6-week intervals. Horses had serum IgM concentrations ranging from 50 to 242 mg/dL over 5 months, with 20% of horses having IgM , 60 mg/dL. The normal range for IgM in fit horses should be considered 103 ± 40 mg/dL and a cut-point for an IgM deficiency, ,23 mg/dL. IgG concentrations ranged from 1,372 to 3,032 mg/dL. Retrospectively, medical records of adult horses (n = 103) admitted to the Cornell University Hospital for Animals for which serum IgM was measured were examined. Horses were categorized as "lymphoma negative" (n = 34) or "lymphoma positive" (n = 18). The sensitivity and specificity of a serum IgM concentration (,60 mg/dL) for detecting equine lymphoma was 50 and 35%, respectively. At the new cut-point (,23 mg/dL), the sensitivity was low at 28% and the specificity improved to 88%. The negative predictive values at various population prevalences indicate that a horse with a high serum IgM (>23 mg/dL) is unlikely to have lymphoma, whereas the positive predictive value (70%) does not allow for reliable determination of lymphoma in a horse with serum IgM , 23 mg/dL. Therefore, serum IgM concentrations should not be used as a screening test for equine lymphoma. [source]

Serum Immunoglobulin G Concentrations in Calves Fed Fresh Colostrum or a Colostrum Supplement

B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient

Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children

RESPIROLOGY, Issue 2 2004
Matti KORPPI
Objective: The aim of the study was to evaluate the association between antibodies to Chlamydia pneumoniae and the onset of asthma in children. Methodology: In 1996,2000, 122 children aged 1,6 years, who were treated for new asthma as inpatients or outpatients in our hospital, were recruited. For each patient, two controls, matched by age, sex and municipality, were randomly selected from the same population. In 2000, 104 serum samples were available from patients (85%) and 120 from controls (49%) for microimmunofluorescence (MIF) assay for C. pneumoniae and C. trachomatis antibodies, and for enzyme immunoassay (EIA) for C. pneumoniae antibodies. Results: In EIA, the median IgG concentrations were 20 EIU (EIA units) in the patients, and 16 EIU in the controls. IgG was positive (> 30 EIU) in 37 (36%) patients and in 36 (31%) controls. IgA was positive (> 12 EIU) in four (4%) patients and in eight (7%) controls. In MIF, four (4%) patients and seven (6%) controls were IgG positive, and seven were also IgA positive. IgM antibodies were detected in four children by EIA, and in none by MIF. Conclusion: IgG antibodies to C. pneumoniae, though common in 1 to 6-year-old children as detected by EIA, did not differ between newly diagnosed asthma patients and controls in this case-control study. [source]

Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis

ARTHRITIS & RHEUMATISM, Issue 2 2007
Evelien Zonneveld-Huijssoon
Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. Methods In this multicenter cohort study, 234 patients with JIA (ages 1,19 years) were vaccinated with meningococcal serogroup C (MenC) conjugate to protect against serogroup C disease (caused by Neisseria meningitidis). Patients were followed up for disease activity for 1 year, from 6 months before until 6 months after vaccination. IgG antibody titers against MenC polysaccharide and the tetanus carrier protein were determined by enzyme-linked immunosorbent assay and toxin binding inhibition assay, respectively. A serum bactericidal assay was performed to determine the function of the anti-MenC antibodies. Results No change in values for any of the 6 components of the core set criteria for juvenile arthritis disease activity was seen after MenC vaccination. Moreover, no increase in the frequency of disease relapse was detected. Mean anti-MenC IgG concentrations in JIA patients rose significantly within 6,12 weeks after vaccination. Of 157 patients tested, 153 were able to mount anti-MenC IgG serum levels >2 ,g/ml, including patients receiving highly immunosuppressive medication. The 4 patients with a lower anti-MenC antibody response displayed sufficient bactericidal activity despite receiving highly immunosuppressive medication. Conclusion The MenC conjugate vaccine does not aggravate JIA disease activity or increase relapse frequency and results in adequate antibody levels, even in patients receiving highly immunosuppressive medication. Therefore, patients with JIA can be vaccinated safely and effectively with the MenC conjugate. [source]

Pharmacokinetics of anti-D IgG in pregnant RhD-negative women

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Issue 1 2003
Johann Bichler
Objective To assess the pharmacokinetics of anti-D IgG in pregnant Rhesus D-negative women after intramuscular and intravenous administration of 300 ,g of Rhophylac. Design An open, randomised, multicentre study. Setting Seven gynaecological practices in Germany. Sample Fourteen RhD-negative pregnant women at risk of becoming Rhesus D immunised received study drug at 28th week of pregnancy either by intramuscular or intravenous route. Main outcome measures Anti-D IgG concentrations of serum samples obtained up to 11 weeks following antenatal Rhesus D prophylaxis were quantified by flow cytometry. Results Mean anti-D IgG concentrations after intravenous and intramuscular administration differed up to seven days post-injection, from two weeks onwards they were comparable to each other. Irrespective of the administration route, anti-D IgG in serum was detectable in all women up to at least nine weeks post-administration. Conclusions The serum concentrations of anti-D IgG measured after administration of Rhophylac were very similar to those obtained with 300 ,g of a different anti-D immunoglobulin product. [source]